Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment

about

Pilot, Randomized, Blinded, Placebo-Controlled Trial Investigating the Correlation Between Acid Control and Heartburn Relief with 14 Days of Esomeprazole Treatment

Item

http://www.wikidata.org/entity/Q59130504

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Pilot, Randomized, Blinded, Pl ...... Days of Esomeprazole Treatment

@en

Pilot, Randomized, Blinded, Pl ...... Days of Esomeprazole Treatment

@nl

type

Item

label

Pilot, Randomized, Blinded, Pl ...... Days of Esomeprazole Treatment

@en

Pilot, Randomized, Blinded, Pl ...... Days of Esomeprazole Treatment

@nl

prefLabel

Pilot, Randomized, Blinded, Pl ...... Days of Esomeprazole Treatment

@en

Pilot, Randomized, Blinded, Pl ...... Days of Esomeprazole Treatment

@nl

P1476

Pilot, Randomized, Blinded, Pl ...... Days of Esomeprazole Treatment

@en

P2093

Charles Pollack

http://www.w3.org/2001/XMLSchema#string

David A Johnson

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Philip B Miner

http://www.w3.org/2001/XMLSchema#string

Philip O Katz

http://www.w3.org/2001/XMLSchema#string

Sergio C Gatoulis

http://www.w3.org/2001/XMLSchema#string

P2860

The pharmacology of the gastric acid pump: the H+,K+ ATPase

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.

Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.

Guidelines for the diagnosis and management of gastroesophageal reflux disease.

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.

Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease.

Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.

Prevention of relapse of healed reflux esophagitis is related to the duration of intragastric pH > 4.

Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy.

Acid control with esomeprazole and lansoprazole: a comparative dose-response study.

P2888

s12325-018-0792-z

P304

2024-2040

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-018-0792-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30255418

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

6224004

http://www.w3.org/2001/XMLSchema#string